N-methylation underlying Parkinson's disease

Kazuo Matsubara, Koji Aoyama, Manabu Suno, Toshio Awaya

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

The discovery of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) leads to the hypothesis that Parkinson's disease (PD) is maybe initiated or precipitated by environmental or endogenous toxins by the mechanism similar to that of MPTP in genetically-predisposed individuals. Endogenous analogs of MPTP, such as β-carbolines (βCs) and tetrahydroisoquinolines, have been proposed as possible causative candidates causing PD and are bioactivated into potential neurotoxins by N-methylation enzyme(s). These N-methylated βCs and tetrahydroisoquinoline have been higher cerebrospinal levels in parkinsonian patients than age-matched controls. Thus, there is a hypotheses to influence the pathogenesis of PD, that is, the excess enzyme activity to activate neurotoxins, such as N-methyltransferase, might be higher in PDs. Indeed, simple βCs, via N-methylation steps, induced bradykinesia with the decreased dopamine contents in the striatum and midbrain in C57/BL mice. In younger (65 years old) PD patients, the excretion amount of N1-methyl-nicotinamaide was significantly higher than that in younger controls. The protein amount of nicotinamide N-methyltransferase (NNMT) was also significantly higher in younger PD patients than that in younger controls. These findings described here would indicate that the excess N-methylation ability for azaheterocyclic amines, such as βCs, before the onset had been implicated in PD pathogenesis. On the other hand, the contribution of aberrant cytochrome P450 or aldehyde oxidase activity acting on the pyridine ring, that could act as detoxification routes of endogenous neurotoxins, would be small in the etiology of PD.

Original languageEnglish
Pages (from-to)593-598
Number of pages6
JournalNeurotoxicology and Teratology
Volume24
Issue number5
DOIs
Publication statusPublished - Sep 2002
Externally publishedYes

Fingerprint

Methylation
Parkinson Disease
Carbolines
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Neurotoxins
Tetrahydroisoquinolines
Nicotinamide N-Methyltransferase
Aldehyde Oxidase
Hypokinesia
Detoxification
Methyltransferases
Enzyme activity
Electron Transport Complex IV
Enzymes
Mesencephalon
Cytochrome P-450 Enzyme System
Amines
Dopamine

Keywords

  • β-Carboline
  • Cerebrospinal fluid
  • N-methylation
  • Neurotoxin
  • Parkinson's disease

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Neuroscience(all)
  • Toxicology

Cite this

N-methylation underlying Parkinson's disease. / Matsubara, Kazuo; Aoyama, Koji; Suno, Manabu; Awaya, Toshio.

In: Neurotoxicology and Teratology, Vol. 24, No. 5, 09.2002, p. 593-598.

Research output: Contribution to journalArticle

Matsubara, Kazuo ; Aoyama, Koji ; Suno, Manabu ; Awaya, Toshio. / N-methylation underlying Parkinson's disease. In: Neurotoxicology and Teratology. 2002 ; Vol. 24, No. 5. pp. 593-598.
@article{a1677d4cacc64094b455d45277ebf647,
title = "N-methylation underlying Parkinson's disease",
abstract = "The discovery of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) leads to the hypothesis that Parkinson's disease (PD) is maybe initiated or precipitated by environmental or endogenous toxins by the mechanism similar to that of MPTP in genetically-predisposed individuals. Endogenous analogs of MPTP, such as β-carbolines (βCs) and tetrahydroisoquinolines, have been proposed as possible causative candidates causing PD and are bioactivated into potential neurotoxins by N-methylation enzyme(s). These N-methylated βCs and tetrahydroisoquinoline have been higher cerebrospinal levels in parkinsonian patients than age-matched controls. Thus, there is a hypotheses to influence the pathogenesis of PD, that is, the excess enzyme activity to activate neurotoxins, such as N-methyltransferase, might be higher in PDs. Indeed, simple βCs, via N-methylation steps, induced bradykinesia with the decreased dopamine contents in the striatum and midbrain in C57/BL mice. In younger (65 years old) PD patients, the excretion amount of N1-methyl-nicotinamaide was significantly higher than that in younger controls. The protein amount of nicotinamide N-methyltransferase (NNMT) was also significantly higher in younger PD patients than that in younger controls. These findings described here would indicate that the excess N-methylation ability for azaheterocyclic amines, such as βCs, before the onset had been implicated in PD pathogenesis. On the other hand, the contribution of aberrant cytochrome P450 or aldehyde oxidase activity acting on the pyridine ring, that could act as detoxification routes of endogenous neurotoxins, would be small in the etiology of PD.",
keywords = "β-Carboline, Cerebrospinal fluid, N-methylation, Neurotoxin, Parkinson's disease",
author = "Kazuo Matsubara and Koji Aoyama and Manabu Suno and Toshio Awaya",
year = "2002",
month = "9",
doi = "10.1016/S0892-0362(02)00212-X",
language = "English",
volume = "24",
pages = "593--598",
journal = "Neurotoxicology and Teratology",
issn = "0892-0362",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - N-methylation underlying Parkinson's disease

AU - Matsubara, Kazuo

AU - Aoyama, Koji

AU - Suno, Manabu

AU - Awaya, Toshio

PY - 2002/9

Y1 - 2002/9

N2 - The discovery of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) leads to the hypothesis that Parkinson's disease (PD) is maybe initiated or precipitated by environmental or endogenous toxins by the mechanism similar to that of MPTP in genetically-predisposed individuals. Endogenous analogs of MPTP, such as β-carbolines (βCs) and tetrahydroisoquinolines, have been proposed as possible causative candidates causing PD and are bioactivated into potential neurotoxins by N-methylation enzyme(s). These N-methylated βCs and tetrahydroisoquinoline have been higher cerebrospinal levels in parkinsonian patients than age-matched controls. Thus, there is a hypotheses to influence the pathogenesis of PD, that is, the excess enzyme activity to activate neurotoxins, such as N-methyltransferase, might be higher in PDs. Indeed, simple βCs, via N-methylation steps, induced bradykinesia with the decreased dopamine contents in the striatum and midbrain in C57/BL mice. In younger (65 years old) PD patients, the excretion amount of N1-methyl-nicotinamaide was significantly higher than that in younger controls. The protein amount of nicotinamide N-methyltransferase (NNMT) was also significantly higher in younger PD patients than that in younger controls. These findings described here would indicate that the excess N-methylation ability for azaheterocyclic amines, such as βCs, before the onset had been implicated in PD pathogenesis. On the other hand, the contribution of aberrant cytochrome P450 or aldehyde oxidase activity acting on the pyridine ring, that could act as detoxification routes of endogenous neurotoxins, would be small in the etiology of PD.

AB - The discovery of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) leads to the hypothesis that Parkinson's disease (PD) is maybe initiated or precipitated by environmental or endogenous toxins by the mechanism similar to that of MPTP in genetically-predisposed individuals. Endogenous analogs of MPTP, such as β-carbolines (βCs) and tetrahydroisoquinolines, have been proposed as possible causative candidates causing PD and are bioactivated into potential neurotoxins by N-methylation enzyme(s). These N-methylated βCs and tetrahydroisoquinoline have been higher cerebrospinal levels in parkinsonian patients than age-matched controls. Thus, there is a hypotheses to influence the pathogenesis of PD, that is, the excess enzyme activity to activate neurotoxins, such as N-methyltransferase, might be higher in PDs. Indeed, simple βCs, via N-methylation steps, induced bradykinesia with the decreased dopamine contents in the striatum and midbrain in C57/BL mice. In younger (65 years old) PD patients, the excretion amount of N1-methyl-nicotinamaide was significantly higher than that in younger controls. The protein amount of nicotinamide N-methyltransferase (NNMT) was also significantly higher in younger PD patients than that in younger controls. These findings described here would indicate that the excess N-methylation ability for azaheterocyclic amines, such as βCs, before the onset had been implicated in PD pathogenesis. On the other hand, the contribution of aberrant cytochrome P450 or aldehyde oxidase activity acting on the pyridine ring, that could act as detoxification routes of endogenous neurotoxins, would be small in the etiology of PD.

KW - β-Carboline

KW - Cerebrospinal fluid

KW - N-methylation

KW - Neurotoxin

KW - Parkinson's disease

UR - http://www.scopus.com/inward/record.url?scp=0036716957&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036716957&partnerID=8YFLogxK

U2 - 10.1016/S0892-0362(02)00212-X

DO - 10.1016/S0892-0362(02)00212-X

M3 - Article

VL - 24

SP - 593

EP - 598

JO - Neurotoxicology and Teratology

JF - Neurotoxicology and Teratology

SN - 0892-0362

IS - 5

ER -